JAKAFI

Formula & Concentration

JAKAFI – ruxolitinib 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg tablet

Manufacturer

Incyte Corporation

Indications

polycythemia vera; graft-versus-host disease; myelofibrosis; chronic graft-versus-host disease

Product Options

Package Size

NDC #

Presentation

5 MG

50881-0005-60

TABLET

10 MG

50881-0010-60

TABLET

15 MG

50881-0015-60

TABLET

20 MG

50881-0020-60

TABLET

25 MG

50881-0025-60

TABLET

Shelf Life and Storage

Store at room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F)